BioCryst Pharmaceuticals (United States)
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a commercial stage biotech company that focuses on developing and commercializing medicines for hereditary angioedema and other rare diseases. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for BioCryst Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
44%
Total
Publications
252
Total Open
Publications
112
Total
Citations
7.1K
Open Access
Percentage
44%
Total
Publications
252
Total Open
Publications
112
Total
Citations
7.1K
Breakdown
Publisher Open
18%
Both
17%
Other Platform Open
10%
Closed
55%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 37%
33
Hybrid 19%
17
No Guarantees 44%
39
Other Platform Open
Domain 68%
47
Institution 36%
25
Other Internet 22%
15
Public 3%
2
Preprint 1%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 48 |
DOI | Other Internet | 14 |
doaj.org OAI-PMH Repository | Institution | 12 |
Washington University in St. Louis | Institution | 4 |
Jagiellonian University | Institution | 3 |
Goethe University Frankfurt | Institution | 3 |
Unknown Repository | Other Internet | 2 |
University of Zurich | Institution | 2 |
University of Southern Denmark | Institution | 2 |
Figshare | Public | 2 |